ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PDX Pursuit Dynamic

1.975
0.00 (0.00%)
05 Jul 2024 - Closed
Delayed by 15 minutes
Pursuit Dynamic Investors - PDX

Pursuit Dynamic Investors - PDX

Share Name Share Symbol Market Stock Type
Pursuit Dynamic PDX London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.975 01:00:00
Open Price Low Price High Price Close Price Previous Close
1.975 1.975
more quote information »

Top Investor Posts

Top Posts
Posted at 26/2/2013 15:49 by hippo
well that's it, sneak out the results, confirming it's all over..........

Sad for a couple of investors here, who may have listened to the Dense and thought he knew what he was on about........but otherwise very predictable.
Posted at 14/2/2013 20:04 by a1ord53
PDX is scam of the century - reliable milk cow for management-no results, no responsibilities and still funding coming again again and again..... ! Investors and Institutions are idiots and nothing else IMHO )
Posted at 31/1/2013 18:35 by a1ord53
Shares magazine, Investors Chronicles and other published recommendations are mostly - paid recommendations- and statistically are better advises to sell and not to buy- recommendation BUY - Sell it - IMHO .
And Denc did do his job brilliantly,too and sold his sole and betrayed people who were believing him and did trust his "knowledge" - let him judge himself - I can judge only myself ....
Posted at 04/1/2013 17:01 by mulligut
wrey and I thought I was the cynic on this board recently. The question is not whether there are any firesales, but any sales. These guys have had so many lines of business over the years that you would imagine that at least one or two of them would work out. It hardly seems likely that they will be given the multi-millions again by investors to be so speculative. So, if they are culling staff then perhaps some of those leaving might have an interest in buying out the areas they were working in. That said, these are the same people who blew millions on their failed attempts. So I can't see any sell off if nothing so far is profitable.
Posted at 29/12/2012 01:01 by daniel
I feel some of these companies of which this is one of the worst, has come to represent the worst of the AIM outfit and the very shame of the British entrepreneurial skills.
The option is a shameless disgrace from those who have just wiped out their investors. Something needs to change in the system. Otherwise,our country will become the quagmire of investors and perceived as a den of rouges - or is it not already is?
Posted at 03/12/2012 16:44 by mulligut
considering the last 12 months news they did well to get the funding over the line. Investors must have been given some insight into what is going on. They could do with some big brewery or food deals coming through to give the share a boost after the size of dilution we have just had to endure.

Outsize it seems that you were right. They close the round and the share price drops below 3p. Not raising the full amount in the Open Offer means that not everyone believes anymore
Posted at 12/10/2012 08:50 by sageofnowhere
Having written off my stake, i'm just an interested observer these days. The strategy section of the pdx website now says that the company is under strategic review and refers readers to the most recent RNS for more information. It seems that we are into another one of those binary periods, much like the weeks running up to the P&G decision / announcement, whereby if the company can secure funding it will be in a position to confirm and implement its revised strategy, and if funding is declined all will seemingly be lost for existing investors. So presumably a huge amount of schmoozing is taking place behind the scenes, which may well be further distracting the management team from the other priority of winning some business.

If i was a potential buyer of pdx's products, my main concern would be with respect to after-sales support. There is simply no assurance that pdx will still be around in 6 months time to provide ongoing support to buyers of its disinfectant units. They may not even be able to deliver on follow up orders, if they run out of cash completely. If i worked for a sophisticated buyer, like a national army for example, basic due diligence would seek to confirm the durability of the chosen provider, to avoid public outrage if nothing else. PDX is marketing sophisticated products to sophisticated buyers, buy with only a small residual cash pile and no track record. At present, PDX is looking to its investors AND its potential customers for a leap of faith. Given past experience, this is an unenviable task.
Posted at 05/10/2012 15:30 by sageofnowhere
Based on the info that's currently in the public domain, there's no grounds for participating in any rights issue. There is no specific information about the scale, probability and timing of possible contracts. We have been told before that the pipeline is promising, but the Media can't write article about this company without using the words "Jam-tomorrow" in the first sentence. Institutional investors will be key, and presumably will be once bitten twice shy and should demand much greater assurances / evidence from PDX that in this case the insertion of funds will lead to revenue generation. If the rights issue is underwritten, we PI's may again be tempted to participate, although it has been said on these boards before that private investors have put too much faith in the institutions and followed them downwards. If I was the credit team contemplating a loan application, this wouldn't get past the first page. My opinion is that credit would (or perhaps I mean should) not be available to PDX, given their track record. IMO, the most likely financing scenario remains a dilutive rights issue, which it would be worth existing shareholders participating in only if, contrary to previous exercises, PDX is willing and able to offer proper guidance on the revenue pipeline and precise use of proceeds.
Posted at 21/9/2012 13:37 by sageofnowhere
yep - we've had three feel good "we're trying reasonably hard" stories, which are presumably intended to reassure existing investors and/or encourage new investors to climb on board ahead of the now seemingly inevitable attempted cash call. What is the company actually saying? Not much. But then, the current share price provides all the information that we need.
Posted at 23/5/2012 20:28 by dafad
INTERESTING!!!!




Procter & Gamble Co. (PG) pledged to stabilize its largest, most-profitable businesses before spending any money on further emerging-market expansion, where Chief Financial Officer Jon Moeller said the company may have been overzealous in chasing growth.

Moeller laid out a strategy to prioritize spending in its upcoming fiscal year in its 40 largest business lines--P&G says it operates in over 1,000 country-category combinations--mainly in North America and China. The product lines, which include businesses like razor blades, laundry and diapers in North America, make up about 50% of P&G's sales.

"We will not spend a dollar outside these core businesses until we are broadly sufficient to win in these markets," Moeller said at a Citigroup conference Wednesday. "We're focusing on the health and competitiveness of our core business."

The move appears to heed calls from investors to at least partially abandon P&G's strategy of trying to push into more markets to get its vast portfolio of everyday goods into the hands of more people, and focus more on its core business lines.

Moeller said P&G may have been better served by a more-measured pace of growth in emerging markets. "We may have overextended ourselves a bit with our pace of expansions," he said.

Like many other consumer-staples companies, P&G has been pushing deeper into emerging markets in recent years, looking for outsized growth rates. Developing markets now make up about 37% of P&G's total sales, up from 20% in 2000, and organic sales, which exclude currency translation, acquisitions and divestitures, have been rising at double-digit percentage rates over the past year.

But the sales are less profitable in developing markets than they are in developed ones, lowering P&G's margins. UBS analyst Nik Modi said penetrating emerging markets is expensive and the competition is high as more global companies push into the space. "The general level of return is lower than what a lot of companies and investors have been expecting," Modi said.

P&G's new tack appears to be tacitly acknowledging the company didn't adjust its growth strategy quickly enough to shift focus back to developed markets, where growth rates had slowed and commodity costs were hurting profits. "Investors look to staples companies for consistency, and they didn't leave themselves enough cushion," Modi said.

Moeller said once P&G determines that its core businesses are in a position to expand, it will turn toward investing in the rest of the portfolio, starting with 10 emerging markets that have the most promise. P&G still expects either high-single or low double-digit percentage growth from its emerging-markets businesses, offsetting weakness in developed markets.

On those largest business lines, P&G said it is looking at whether it needs to lower prices in areas, much like it recently did on oral care, razor blade and dishwashing detergent in North America, and laundry in a couple other areas.

"We will not lose share because prices are too high," Moeller said. "We're closely monitoring a few additional situations and adjust as necessary."

P&G shares fell 1.6% in recent trading to $62.15, while the Dow Jones Industrial Average was down 1.3%. The world's largest consumer-products company is undertaking a $10 billion restructuring program that will last four years.

-By Paul Ziobro, Dow Jones Newswires; 212-416-2194 ; paul.ziobro@dowjones.com; Twitter: @pziobro

Your Recent History

Delayed Upgrade Clock